NEW YORK, Oct. 10 – Qiagen said on Wednesday that it has received an exclusive license to market and distribute Kreatech Biotechnology’s ULS labeling technologies in combination with its resonance light scattering products.

In addition, Qiagen acquired non-exclusive rights to develop and sell ULS products for labeling and detecting nucleic acids and proteins in microarray experiments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.